Mayo Clinic proceedings

Mayo Clinic proceedings
Audio Summaries

Every issue of Mayo Clinic proceedings moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.

108 audio summariesNLM Catalog

Specialties

Mayo Clinic proceedings covers research in these specialties.

Recent summaries

The latest articles summarized from Mayo Clinic proceedings.

Patient-Staff Interaction in ED by Real-time Location System: Novel Predictors of In-hospital Mortality Enhancing APACHE III/APS in ICU Patients.

Nov 20, 2026

This single-center retrospective cohort study of 757 adults admitted from the emergency department to the ICU asked whether real-time location system (RTLS)-measured staff-patient interactions (co-location for at least 2 minutes) predict in-hospital mortality beyond physiological severity and improve APACHE III. Six interaction features were independently associated with mortality, and their combined discrimination was moderate (AUROC about 0.70). Adding these RTLS features to APACHE III significantly improved discrimination, precision-recall performance, and net reclassification, with "total unique co-located nurses" and "time in patient room" contributing most of the predictive weight; the authors call for multicenter validation.

SGLT2 Inhibitors Versus Metformin as First-Line Therapy for Cardiorenal Outcomes: A Target Trial Emulation Among New Users With Type 2 Diabetes.

Nov 18, 2026

This target trial emulation using TriNetX data asked whether initiating an SGLT2 inhibitor versus metformin as first-line therapy for type 2 diabetes is linked to better cardiorenal and mortality outcomes. In 36,720 propensity-matched pairs, SGLT2 inhibitor initiation was associated with lower risks of MACE (HR 0.88), all-cause mortality (HR 0.73), stroke, cardiac arrest, and acute heart failure, with no significant difference in myocardial infarction or kidney replacement therapy. Because the study is observational, these associations are subject to residual confounding and cannot establish causation.

Effects of Sauna Bathing on NMR-Based Metabolomic Profiles.

Nov 12, 2026

Researchers asked whether Finnish sauna bathing alters circulating metabolomic markers of lipid and amino acid metabolism, using NMR profiling in two groups: habitual sauna users exposed acutely to a 30-minute session, and sedentary adults in an 8-week trial comparing exercise alone with exercise plus post-exercise sauna. A single sauna session lowered triglycerides, VLDL particles, and branched-chain and aromatic amino acids while raising ketone bodies, consistent with enhanced lipid use and a transient stress response. Adding sauna to exercise produced further benefits over exercise alone, including reduced LDL particle concentration, greater VLDL reductions, and larger HDL particles, suggesting heat exposure may augment exercise-related improvements in lipoprotein profiles.

A Validated Artificial Intelligence Model Versus Urinary Supersaturation Alone for Predicting Kidney Stone Composition.

Nov 12, 2026

This study asks whether an artificial intelligence model built on demographics and 24-hour urine supersaturation panel results can predict kidney stone composition more accurately than the EQUIL2 supersaturation algorithm alone. The model was trained on about 13,000 patients and validated on 1,653 held-out paired measurements, where it achieved 0.73 accuracy versus 0.33 for supersaturation alone. The AI model also outperformed supersaturation across age and sex subgroups and previously published AI models for calcium oxalate, calcium phosphate, and uric acid stones.

Diet Quality Versus Physical Activity and Cardiorespiratory Fitness for Longevity: A Review of Comparative Evidence.

Nov 11, 2026

This review asks whether diet quality, physical activity (PA), or cardiorespiratory fitness (CRF) matters more for all-cause mortality, drawing on meta-analyses and prospective cohort studies found in PubMed. The authors conclude that a sedentary lifestyle carries greater excess mortality risk than poor diet, and that high PA or CRF is linked to larger mortality reductions than healthy eating, with high fitness often offsetting the risk of low diet quality. They argue that current public health priorities overemphasize diet relative to physical activity and call for greater focus on increasing PA and CRF when longevity is the primary goal.

A National Research Agenda to Advance Physician Well-Being.

Nov 9, 2026

This paper presents a national research agenda developed by a 2025 Physician Well-Being Think Tank convened by Stanford Medicine's WellMD & WellPhD Center, which brought together well-being researchers, chief wellness officers, and healthcare executives. The authors asked what evidence is needed to scale and evaluate effective strategies for physician well-being, burnout, and workforce retention, and through voting and consensus discussions they identified four priority domains: causal links between clinician well-being and system outcomes, scalable organizational interventions, wellness-centered leadership, and optimal interdisciplinary work design. The agenda aims to guide research that can accelerate system-level action and strengthen the long-term stability and performance of the healthcare workforce.

The Future Burden of Type 2 Diabetes and the Role of Glycaemic Control and GLP1-RAs.

Nov 3, 2026

This study used a UK system dynamics model to project the burden of type 2 diabetes from 2024 to 2060, asking how achieving glycaemic targets, with and without population-wide GLP-1 receptor agonist use, would affect prevalence, costs, and complications. Glycaemic control alone was projected to save about £61.4bn, while adding GLP-1 RA cardiorenal benefits raised cumulative savings to about £140.7bn, preventing roughly 4.5 times as many macrovascular complications and 6 times as many deaths. The authors conclude that the cardiorenal protection from GLP-1 RAs provides substantial economic and health value beyond glycaemic control alone.

Whimsical Botanicals by Ursula Hargens.

Nov 2, 2026

This brief Mayo Clinic Proceedings feature is not a research study but an art piece commentary, describing how artwork has been donated or commissioned for Mayo Clinic campuses since the original building was completed in 1914. The author presents a work of art, Ursula Hargens' "Whimsical Botanicals," as interpreted by the author, which is displayed in a Mayo Clinic building or on its grounds. The piece therefore aims to highlight the role of art in the healing environment for patients and staff rather than to answer a scientific question.

Efficacy and Safety of Evogliptin in Mild to Moderate Calcific Aortic Valve Stenosis: The EVOID-AS Trial Rationale and Study Design.

Nov 2, 2026

The EVOID-AS trial asks whether evogliptin, a dipeptidyl peptidase-4 inhibitor, can slow aortic valve calcification and hemodynamic progression in patients with mild to moderate calcific aortic stenosis, a condition with no proven medical therapy. The authors describe a double-blind, placebo-controlled, randomized design in which 580 patients will receive evogliptin 10 mg or placebo daily for 2 years, with the primary endpoint being change in valve calcium score on cardiac CT. Secondary endpoints include echocardiographic progression of stenosis severity, time to aortic valve intervention, and treatment-emergent adverse events.

Feature Selection and Machine Learning Strategies to Develop a Minimal Bioassay for Cholangiocarcinoma Subtype.

Nov 2, 2026

This study asks whether a cheap, clinically feasible RNA sequencing assay can reproduce the molecular subtyping of cholangiocarcinoma that normally requires costly multiomic (RNA, protein, and phosphoprotein) profiling. Using feature selection and machine learning on 249 tumors from Mayo Clinic and Fudan University, the authors found that a panel of just 20 RNA transcripts, classified with gradient boosted trees, achieved 83.8% accuracy and an AUC of 0.961 on reserved test data. The results suggest that combining feature selection with machine learning can make multiomic-based subtyping practical for routine clinical use.

Listen to Mayo Clinic proceedings

14-day free trial. Every new article, summarized in ~3 minutes.